Skip to main content
Pediatric Allergy, Immunology, and Pulmonology logoLink to Pediatric Allergy, Immunology, and Pulmonology
. 2021 Dec 16;34(4):130–131. doi: 10.1089/ped.2021.0162

Telehealth and Remote Patient Monitoring After the COVID Pandemic

Satyanarayan Hegde 1, Nemr S Eid 2,✉
PMCID: PMC8817681  PMID: 34724847

Before the COVID pandemic telehealth and home electronic monitoring were moving along at extremely low speed as compared with many other modern technological innovations. This unexpected and life-shattering pandemic propelled this technology to the forefront of medical revolution. Telehealth was the life-saving technology that allowed patients to see their medical providers at a time when the in-person medical visits were severely constrained. What is surprising is that patients themselves often requested this option from their providers, and recent statistics have shown a significant increase in consumer adoption of telehealth from 11% in 2019 to 46% currently.1 Furthermore, due to the persistent pandemic, the Centers for Medicare and Medicaid Services (CMS) has accelerated the acceptance of telehealth in many ways. It has approved >80 new services and has demonstrated regulatory flexibilities through regulatory waivers, allowing billing for services across state lines, and using Health Insurance Portability and Accountability Act (HIPAA)- and non-HIPAA-compliant platforms without geographic restrictions, to increase access to virtual care.2 Indeed, remote patient monitoring (RPM) has seen an explosion of adoption in Internal Medicine since the COVID pandemic began. According to the most recent National Survey of Children's Health,3 about 34.5% of all children in the United States have public health insurance. However, according to the same survey, the odds of children with chronic respiratory conditions to be on a public health insurance was 1.7 in comparison with a private only health insurance. The odds of these children being on a combination of private and public health insurance increased to 1.9 in comparison with private only health insurance. Since all 50 states and Washington, DC have expanded telehealth access for Medicaid beneficiaries during this pandemic,4 we believe that RPM in pediatrics is ready for prime-time adoption.

RPM enables physicians to provide wellness care and proactive management of chronic diseases. It has several reimbursable codes for patients with 1 or more chronic conditions through dedicated Chronic Care Management (CCM) and regular Evaluation and Management codes. RPM is ideal for patients with chronic conditions such as hypertension, diabetes, obesity, chronic obstructive pulmonary disease (COPD), heart failure, sleep apnea, asthma, and cystic fibrosis. A primary care physician or a cardiologist, for example, can prescribe an automated connected blood pressure monitoring device for proactive management of hypertension. Using RPM and CCM codes, the physician gets reimbursed for reviewing and acting on the physiological data (in this case, blood pressure) monthly provided the appropriate coding and billing rules are followed.

In Pediatric Pulmonology, there are several untapped possibilities that are currently reimbursed by CMS and Commercial Insurance Plans. Imagine a 10-year-old boy with chronic asthma and poorly controlled symptoms who frequently confuses his rescue versus controller inhalers. His inhalation technique is poor such that he does not take a slow deep breath and hold for 5–7 s with a valve holding chamber with a mouthpiece. The treating physician can order an RPM service with a connected electronic peak flow or a spirometer for home use through an RPM company like ordering other devices through a durable medical equipment company. Current Procedural Terminology (CPT) code 99453 can be used for initial setup and education on equipment for which CMS reimburses $19. For devices supply with daily recording(s) or programmed alert(s) transmission, CPT code of 99454 can be used once every month for which CMS currently reimburses $64 per each unit (month). For remote physiological monitoring treatment management services, 20 min or more of clinical staff/physician/other qualified health care professional time per month, under this RPM service, CPT code of 99457 can be used once every month. CMS currently reimburses $52 per each unit (month) for this code. Let us imagine that this patient has been enrolled in an RPM service plan and has a connected spirometer and a pulse oximeter for home use and access to a secure RPM application through his smartphone or tablet. The treating physician orders a care plan that includes twice weekly home spirometry measurement when stable, and daily spirometry whenever the patient needs to take his rescue inhaler. In addition, the patient is to measure his oxygen level whenever he is sick. The physician has ordered alert levels to the spirometry and pulse oximeter such that whenever the forced expiratory volume in the first second falls <10% of baseline or whenever the pulse oximetry readings are <92% on a good signal, the physician's office gets auto notification. Most of the work related to reviewing the physiological data, providing advice and education is done by the physician's clinical staff although the physician provides the overall supervision. Also, by using the RPM's video calling feature, the physician's clinical staff can virtually intervene and coach the patient about proper inhalation technique in time of need, at his home. In other words, they were able to hit the iron “when the iron was hot.” In this scenario, the physician can proactively intervene at early stages of an asthma exacerbation and prevent hospitalization and/or emergency department visits.

However, to sustain the use of telehealth during and beyond the COVID-19 pandemic, a recent study has outlined 5 key requirements necessary for its success and include (1) developing a skilled workforce, (2) empowering consumers, (3) reforming funding arrangements, (4) improving the digital ecosystems, and (5) integrating telehealth into routine clinical workflows.5

The 2 impediments to telehealth and RPM in pediatric pulmonology would seem to be the paucity of available digital ecosystems, and the lack of reimbursement from many insurance carriers for both the patient (rental or leasing of digital equipment) and physician alike (fee for service, support for extra staff needed for digital monitoring). Furthermore, as RPM is a nascent area, there are no randomized clinical trials to charter the way. A search for “remote patient monitoring” on PubMed reveals a total of 413 studies. Of these, there were only 12 randomized clinical trials, and only 1 for the management of patients with severe COPD on home oxygen therapy in Spain.6 This study revealed that remote patient management did not reduce COPD-related emergency department visits or hospital admissions compared with routine clinical practice. Another community-based observational study involving virtual health care with remote monitoring of skin temperature, pulse rate, and oxygen saturation was conducted in mild COVID-19 patients in Australia.7 A total of 162 patients with age range 11–79 years of age were included. Remote monitoring was complemented with virtual video consultations. Overall, the care escalation rate, including ambulance attendance, emergency department visit, or hospitalization, was low and no death occurred. The study showed that in the Australian health care model, virtual care with RPM was safe in a pandemic. A large recent study done by Mayo Clinic involving >7,000 patients in 41 states highlights the development and implementation of large-scale COVID-19 RPM program.8 The authors tested the feasibility, safety, patient engagement with the technology, the role of virtual care teams in patient monitoring, and patient clinical outcome as well as resource utilization. Among patients with acute COVID-19 infections, the RPM technology engagement rate was 78.9%. Rates of emergency department visit and hospitalization within 30 days of enrollment were 11.4% and 9.4%, respectively, and the 30-day mortality rate was 0.4%.7 This study demonstrated a novel approach to prevent severe illness among high-risk patients and to reduce the burden on hospitals and emergency departments during a pandemic surge.

Pediatric pulmonology can be safely and effectively done remotely if digital ecosystems were readily available to patients. Digital stethoscopes, pulse oximeters, and handheld Bluetooth-enabled spirometers can be given or leased to interested patients. In addition to connected devices, the RPM platform should also provide audio and video calling and messaging services. Educated staff on monitoring and responding to patients' complaints in real time assure a skilled workforce that will make virtual care a reality.

We encourage our colleagues in both pediatric pulmonology and allergy to lobby health care industry to provide children-friendly devices for home RPM, and to publish their observations and experiences in dealing with a variety of pediatric lung diseases. Only through our shared experiences can we advance this technology to the next level. As this pandemic changed the practice of health care, the post-COVID pandemic world, once this scourge is contained, is unlikely to resemble anything we knew before. The future impact of telehealth as it relates to children's lung health is in our hands. So let us be good stewards of this important task.

Author Disclosure Statement

No competing financial interests exist.

Funding Information

No funding was received for this article.

References


Articles from Pediatric Allergy, Immunology, and Pulmonology are provided here courtesy of SAGE Publications

RESOURCES